Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04829240 · ClinicalTrials.gov registry record · NA

Brief Anxiety Skills Training Intervention for Veterans in Primary Care

A NA study of Anxiety, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
177
Enrollment target
2
Study locations

NCT04829240: Completed NA study of Anxiety, sponsored by VA Office of Research and Development.

NCT04829240 is a NA study of Anxiety that has completed, run by VA Office of Research and Development. The registered enrollment target is 177 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (60% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04829240, a NA study of Anxiety, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
177 participants
Enrollment target
2
Study locations

Study Summary

Anxiety symptoms are common among primary care patients, but anxiety is undertreated. Brief behavioral (non-medication) anxiety treatments are needed. The purpose of this study is to evaluate whether a brief anxiety treatment designed for VA primary care is more effective at reducing anxiety symptoms and impairment in Veterans compared to usual care. The brief anxiety treatment, Veterans Anxiety Skills Training (VAST), was designed to be evidence-based (emphasis on cognitive-behavioral skills), transdiagnostic (applicable to a wide range of anxiety symptoms), feasible for integrated primary care (no more than 6 brief \[30-minute\] sessions), and Veteran-centered (tailored to Veterans and personalized to individual patients). A total of 170 adult Veteran primary care patients from the Syracuse and Western New York VA healthcare systems who are experiencing anxiety symptoms will be recruited and randomly assigned to receive the brief anxiety treatment or usual care. The investigators will compare anxiety symptom severity and functional impairment between the two groups at baseline and at post-assessment (at 16 weeks) and follow-up assessment (at 28 weeks). The investigators will also examine predictors of treatment response among those receiving VAST and whether providers deliver VAST as intended.

Primary Outcome

Functional impairment from anxiety symptoms will be measured using the Overall Anxiety Severity and Impairment Scale (OASIS), which measures symptom severity and functional impairment across anxiety disorders and subthreshold symptoms. The 5-item scale demonstrates reliability (alpha = .84 in primary care sample) and validity in primary care patients. Participants indicate the frequency and intensity of anxiety, level of avoidance, and interference with activities and social functioning on a Lik

Conditions Studied

Interventions

  • BEHAVIORAL Veterans Anxiety Skills Training Intervention
  • BEHAVIORAL PCMHI Usual Care

Study Locations (2)

New York

  • VA Western New York Healthcare System, Buffalo, NY - Buffalo
  • Syracuse VA Medical Center, Syracuse, NY - Syracuse

Trial Details

FieldValue
Enrollment Target 177 participants
Start Date 2021-08-17
Est. Completion 2025-08-31
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT04829240 record still lists

NCT04829240 is an interventional study that assigns participants to a tested intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (60% lower).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Veterans Anxiety Skills Training Intervention is the first listed.

NCT04829240 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04829240 about?

NCT04829240 is a clinical study titled "Brief Anxiety Skills Training Intervention for Veterans in Primary Care". Anxiety symptoms are common among primary care patients, but anxiety is undertreated. Brief behavioral (non-medication) anxiety treatments are needed. The purpose of this study is to evaluate whether a brief anxiety treatment designed for VA primary care is more effective at reducing anxiety symptom...

What is the current status of trial NCT04829240?

This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2021-08-17. Estimated completion is 2025-08-31.

What conditions does trial NCT04829240 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT04829240?

The interventions under investigation include: Veterans Anxiety Skills Training Intervention (BEHAVIORAL), PCMHI Usual Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT04829240?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04829240 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04829240's enrollment target sits among peer trials

177 98th of 364 higher than 267 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05491551 · 177 participants · NA

    Alcohol-ROC-Training

  • NCT06108050 · 177 participants · Phase 1

    JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

  • NCT06575712 · 177 participants · NA

    Coping Skills Training for Symptom Management and Daily Steps (Step Up)

  • NCT06674980 · 177 participants · NA

    Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04829240, the US trial registry maintained by the National Library of Medicine. NCT04829240 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.